GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solasia Pharma KK (TSE:4597) » Definitions » LT-Debt-to-Total-Asset

Solasia Pharma KK (TSE:4597) LT-Debt-to-Total-Asset : 0.01 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Solasia Pharma KK LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Solasia Pharma KK's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.01.

Solasia Pharma KK's long-term debt to total assets ratio declined from Mar. 2023 (0.02) to Mar. 2024 (0.01). It may suggest that Solasia Pharma KK is progressively becoming less dependent on debt to grow their business.


Solasia Pharma KK LT-Debt-to-Total-Asset Historical Data

The historical data trend for Solasia Pharma KK's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solasia Pharma KK LT-Debt-to-Total-Asset Chart

Solasia Pharma KK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.01 - 0.01

Solasia Pharma KK Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.01 0.01

Solasia Pharma KK LT-Debt-to-Total-Asset Calculation

Solasia Pharma KK's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=27/2229
=0.01

Solasia Pharma KK's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )/Total Assets (Q: Mar. 2024 )
=20/2708
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solasia Pharma KK  (TSE:4597) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Solasia Pharma KK LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Solasia Pharma KK's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Solasia Pharma KK (TSE:4597) Business Description

Traded in Other Exchanges
Address
2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.

Solasia Pharma KK (TSE:4597) Headlines

No Headlines